ClinicalTrials.gov
public full text
Public Domain
Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer#152482
- Nivolumab in Biochemically Recurrent dMMR Prostate Cancer#835407
- Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature#1101995
- Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7#1075089
- Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer#897717
Record · ID 261521
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive